Core Viewpoint - Itron, Inc. has announced a private offering of $700 million in 0.00% convertible senior notes due 2032, increasing from a previously announced $600 million, with an option for initial purchasers to buy an additional $105 million [1][7] Group 1: Offering Details - The notes will not bear regular interest and will mature on March 15, 2032, unless converted, redeemed, or repurchased earlier [2] - The initial conversion rate is set at 8.0793 shares per $1,000 principal amount, equating to a conversion price of approximately $123.77 per share, which is a 30% premium over the last reported sale price of $95.21 on February 23, 2026 [2] - The notes can be converted by holders only during specific periods before December 15, 2031, and at any time thereafter until the maturity date [2] Group 2: Redemption and Repurchase - The notes are redeemable at the company's option starting March 20, 2030, if the stock price exceeds 130% of the conversion price for a specified period [3] - Holders can require the company to repurchase their notes at 100% of the principal amount plus any accrued interest upon a "fundamental change" [3] Group 3: Capped Call Transactions - The company has entered into capped call transactions to reduce potential dilution upon conversion of the notes, with an initial cap price of $190.42 per share [4] - These capped call transactions may lead to increased market price volatility for the common stock and the notes [5][6] Group 4: Use of Proceeds - The company estimates net proceeds from the offering to be approximately $681.1 million, which may increase to $783.3 million if the option for additional notes is fully exercised [7] - Approximately $80.7 million of the proceeds will be used for capped call transaction costs, and $100 million will be allocated for repurchasing 1,050,309 shares of common stock [7] - Remaining proceeds will be used for repaying existing convertible senior notes due 2026 and for general corporate purposes [7]

Core Insights - CHC Navigation (CHCNAV) has launched the RS7, a handheld SLAM scanning solution aimed at enhancing BIM documentation, indoor surveying, renovation planning, and complex spatial analysis [1][9] Group 1: Product Features - The RS7 integrates a next-generation LiDAR scanner that can measure up to 1.15 million points per second, with a wide field of view of 360° x 189°, allowing for comprehensive coverage and reducing the need for repeated passes in complex environments [2] - It includes a high precision inertial measurement unit with bias stability better than 0.5°/h, ensuring stable motion estimation and consistent point cloud quality in challenging mobile workflows [2] - The RS7 supports high fidelity visualization with dual 12-megapixel cameras optimized for low light, utilizing the CHCNAV HPGS 2.0 engine for photorealistic scene rendering through 3D Gaussian Splatting outputs [4] Group 2: Workflow Integration - The RS7 is supported by CHCNAV's software ecosystem, facilitating an integrated workflow from scan setup to data review and post-processing, which can reduce turnaround time and lower technical barriers for users [3] - The "Cloud + Terminal" workflow allows for centralized project and data management, enabling automated processing of field datasets to generate deliverables like registered point clouds and mesh models [3] Group 3: Company Overview - CHC Navigation specializes in mapping, navigation, and positioning technologies, serving industries such as geospatial, agriculture, construction, and autonomy [5] - The company operates in over 140 countries and employs more than 2,200 professionals globally, focusing on integrated solutions that enhance productivity and efficiency in spatial data management [5]

Company Overview - ClearThink 1 Acquisition Corp. is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, focusing on the financial services sector in the United States and other developed countries [6]. Initial Public Offering (IPO) Details - The company announced its initial public offering of 12,500,000 units priced at $10.00 per unit, with units expected to be listed on the Nasdaq Global Market under the ticker symbol "CTAAU" starting February 24, 2026 [1]. - Each unit consists of one Class A ordinary share and one right to receive one-fifth of one Class A ordinary share, with separate trading expected for the Class A ordinary shares and rights under the symbols "CTAA" and "CTAAR" respectively [1]. Underwriting and Closing Information - D. Boral Capital LLC is acting as the sole book-running manager for the offering, which includes a 45-day option for underwriters to purchase up to an additional 1,875,000 units to cover overallotments [2]. - The offering is anticipated to close on February 25, 2026, subject to customary closing conditions [2]. Regulatory and Legal Information - A registration statement for these securities was declared effective by the Securities and Exchange Commission on February 13, 2026, and the offering is being made only by means of a prospectus [3]. - Legal counsel for the company includes Ruskin Moscou Faltischek, P.C. as U.S. counsel and Ogier (Cayman) LLP as Cayman Islands counsel [4].

Core Viewpoint - Alkane Resources Limited has announced significant exploration results and drilling activities aimed at expanding the underground resources at its Tomingley Gold Operations in New South Wales, indicating strong potential for resource expansion both near the mine and regionally [1][4]. Exploration Results - The exploration at Tomingley has revealed extensions to existing deposits and new areas of mineralization, with ongoing drilling demonstrating substantial resource expansion potential [4]. - Recent drilling at the Roswell deposit has confirmed high-grade gold zones, with notable intercepts including 5.9 meters grading 31.0 g/t Au and 17.4 meters grading 4.30 g/t Au [6][16][19]. - At the El Paso prospect, significant results include 17 meters grading 4.02 g/t Au, with high-grade intervals of 14.1 g/t Au and 77.5 g/t Au [22]. Resource Estimates - The Roswell underground resources are estimated at 5.5 million tonnes grading 2.6 g/t Au, totaling approximately 476,000 ounces of gold [11][30]. - The total mineral resources at Tomingley as of June 2025 amount to 19.234 million tonnes with an average grade of 2.2 g/t Au, equating to 1,358,000 ounces of gold [30][33]. Development and Future Plans - The company plans to continue its exploration drilling at the Wyoming Three deposit and the northern extensions of the main andesite host at Caloma, with a second phase of drilling expected to be completed by Q3 2026 [27][28]. - Further exploration efforts will focus on identifying new targets outside the Tomingley Gold Operations, including additional drilling at the Westray prospect [21][26]. Operational Overview - The Tomingley Gold Operations include both open pit and underground mining developments, with a processing facility operating since 2014, located approximately 50 kilometers southwest of Dubbo [5][46]. - Alkane Resources operates three mines across Australia and Sweden, with ongoing regional exploration aimed at growing resources at all operations [48].

Core Viewpoint - Alkane Resources Limited has announced significant exploration results and drilling activities aimed at expanding the underground resources at its Tomingley Gold Operations in New South Wales, indicating strong potential for resource expansion both near the mine and regionally [4][5]. Exploration Results - The exploration at Tomingley has revealed extensions to existing deposits and new areas of mineralization, with ongoing drilling demonstrating significant resource expansion potential [4][6]. - Recent drilling at the Roswell deposit has confirmed high-grade gold zones, with notable intercepts including 5.9 meters grading 31.0 g/t Au and 17.4 meters grading 4.30 g/t Au [7][17][21]. - The Roswell underground resources are estimated at 5.5 million tonnes grading 2.6 g/t Au, equating to an endowment of 476,000 ounces of gold [11][34]. Drilling Programs - A program of underground drilling at Roswell has been completed, confirming multiple high-grade gold zones within the Western Monzodiorite domain [16][17]. - Exploration drilling at the El Paso prospect has also yielded significant results, including 17 meters grading 4.02 g/t Au [24][39]. - The company has initiated further drilling to test the upper and lower portions of the Inferred domain at Roswell, with completion expected by Q3 2026 [29]. Resource and Reserve Estimates - As of June 30, 2025, the total mineral resources at Tomingley Gold Operations are reported at 19.234 million tonnes with an average grade of 2.2 g/t Au, totaling approximately 1.358 million ounces of gold [33][34]. - The total ore reserves are reported at 10.362 million tonnes with an average grade of 1.9 g/t Au, amounting to approximately 621,000 ounces of gold [35]. Future Exploration Plans - The company plans to conduct further surface exploration drilling at the Wyoming Three deposit and the northern extensions of the main andesite host at Caloma [29]. - Additional drilling at El Paso is planned to confirm the updated geological model and test for extensions to known mineralization [31].

Core Viewpoint - A securities fraud lawsuit has been filed against Navan, Inc. and certain executives, alleging inadequate disclosure in the company's IPO materials regarding increased sales and marketing spending and slowing revenue trends [2]. Group 1: Lawsuit Details - The lawsuit claims that Navan's IPO offering materials, dated October 31, 2025, failed to disclose significant increases in sales and marketing expenses while the company was experiencing slowing revenue trends necessary to maintain reported growth metrics [2]. - Navan sold approximately 36.9 million shares at $25 per share during the IPO [2]. - Following the disclosure of increased sales and marketing expenses and the departure of the Chief Financial Officer on December 15, 2025, Navan's stock price fell to $12.90 per share the next trading day [2]. Group 2: Eligibility and Actions - Investors who purchased Navan common stock and experienced a decline in share value may be eligible to participate in the lawsuit, regardless of whether they sold their shares [3]. - The deadline to seek appointment as lead plaintiff is April 24, 2026, and a class has not yet been certified [4]. Group 3: Whistleblower Information - Individuals with non-public information about Navan are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [5]. Group 4: Firm Background - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [6].

Core Viewpoint - A class action lawsuit has been filed against Navan, Inc. for allegedly misleading investors regarding its IPO and subsequent financial performance, leading to significant losses for shareholders [2][7]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Northern District of California on behalf of all individuals and entities who purchased Navan securities based on the Offering Documents [2]. - Investors have until April 24, 2026, to apply to be appointed as lead plaintiff in the lawsuit [2]. Group 2: Allegations - The complaint alleges that the Offering Documents used during Navan's IPO were false and misleading, failing to disclose an increase in "sales and marketing" expenses at the time of the offering [7]. - As a result of the revelations about the company's business practices, Navan's share price fell dramatically, trading as low as $9.01 per share, which is over a 60% decline from the IPO price of $25.00 per share [7]. Group 3: Company Background - Navan conducted its initial public offering on October 30, 2025, selling approximately 36.9 million shares [7]. - Bragar Eagel & Squire, P.C. is a law firm representing investors in this case, with a focus on securities and commercial litigation [5].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Corcept (CORT) To Contact Him Directly To Discuss Their Options If you purchased or acquired Corcept common stock between October 31, 2024, and December 30, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- What’s Happeni ...

Core Viewpoint - A class action lawsuit has been filed against Ostin Technology Group Co., Ltd. for alleged securities fraud during the class period from May 11, 2025, to June 26, 2025, with significant losses reported by investors [2][5]. Allegation Details - The lawsuit alleges that on September 12, 2025, a criminal indictment was unsealed against Ostin's co-CEO Lai Kui Sen and financial advisor Yan Zhao, charging them with conspiracy to commit securities fraud and wire fraud, resulting in over $110 million in illicit proceeds [5]. - The complaint claims that starting in April 2025, Lai Kui Sen and co-conspirators executed fraudulent securities offerings, allowing them to acquire Ostin shares at minimal or no cost, while simultaneously inflating the stock price through deceptive promotional campaigns [5]. - Ostin's market capitalization reportedly increased from approximately $22 million to over $1 billion during the class period, with the stock price peaking at $9.40 on June 26, 2025, before a significant selloff led to a loss of over $950 million in market capitalization in one day [5]. Next Steps - Investors who purchased Ostin shares and suffered losses are encouraged to contact Bragar Eagel & Squire, P.C. for more information regarding their rights and potential claims [4].

Core Insights - Supernus Pharmaceuticals, Inc. is actively participating in multiple investor conferences in March 2026, showcasing its commitment to engaging with investors and stakeholders in the biopharmaceutical sector [1][2][3]. Conference Participation - The company will attend the TD Cowen 46th Annual Health Care Conference on March 2, 2026, with a fireside chat scheduled for 2:30 p.m. ET in Boston, Massachusetts [1]. - Supernus will also participate in the Jefferies Biotech on the Beach Summit on March 10, 2026, held in Miami Beach, Florida [2]. - Additionally, the company is set to present at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026, with a fireside chat at 2:00 p.m. ET in Miami Beach, Florida [3]. Webcast Availability - Live audio webcasts of the TD Cowen and Barclays Conference presentations will be accessible on the Supernus Pharmaceuticals website, with archived replays available for 60 days post-conference [4]. Company Overview - Supernus Pharmaceuticals focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases, indicating a specialized niche within the biopharmaceutical industry [5]. - The company's neuroscience portfolio includes approved treatments for various conditions such as ADHD, Parkinson's disease-related dyskinesia, postpartum depression, epilepsy, and migraine, among others [6].